Cancer drug costs for a month of treatment at initial Food and Drug Administration approval Year of FDA Monthly Cost Monthly cost Generic name Brand name(s) approval (actual $'s) (2014 $'s) vinblastine Velban 1965 $78 $585 thioguanine, 6-TG Thioguanine Tabloid 1966 $17 $124 hydroxyurea Hydrea 1967 $14 $99 cytarabine Cytosar-U, Tarabine PFS 1969 $13 $84 procarbazine Matulane 1969 $2 $13 testolactone Teslac 1969 $179 $1,156 mitotane Lysodren 1970 $134 $814 plicamycin Mithracin 1970 $50 $305 mitomycin C Mutamycin 1974 $5 $23 dacarbazine DTIC-Dome 1975 $29 $127 lomustine CeeNU 1976 $10 $42 carmustine BiCNU, BCNU 1977 $33 $129 tamoxifen citrate Nolvadex 1977 $44 $170 cisplatin Platinol 1978 $125 $453 estramustine Emcyt 1981 $420 $1,092 streptozocin Zanosar 1982 $61 $149 etoposide, VP-16 Vepesid 1983 $181 $430 interferon alfa 2a Roferon A 1986 $742 $1,601 daunorubicin, daunomycin Cerubidine 1987 $533 $1,109 doxorubicin Adriamycin 1987 $521 $1,084 mitoxantrone Novantrone 1987 $477 $993 ifosfamide IFEX 1988 $1,667 $3,331 flutamide Eulexin 1989 $213 $406 altretamine Hexalen 1990 $341 $617 idarubicin Idamycin 1990 $227 $411 levamisole Ergamisol 1990 $105 $190 carboplatin Paraplatin 1991 $860 $1,493 fludarabine phosphate Fludara 1991 $662 $1,149 pamidronate Aredia 1991 $507 $880 pentostatin Nipent 1991 $1,767 $3,067 aldesleukin Proleukin 1992 $13,503 $22,750 melphalan Alkeran 1992 $35 $59 cladribine Leustatin, 2-CdA 1993 $764 $1,250 asparaginase Elspar 1994 $694 $1,107 paclitaxel Taxol 1994 $2,614 $4,169 pegaspargase Oncaspar 1994 $3,006 $4,795 vinorelbine Navelbine 1994 $1,035 $1,651 anastrozole Arimidex 1995 $189 $293 bicalutamide Casodex 1995 $311 $482 doxorubicin liposomal Doxil, Dox-SL, Evacet, LipoDox 1995 $1,488 $2,308 goserelin acetate Zoladex 1995 $415 $644 porfimer sodium Photofrin 1995 $520 $807 tretinoin, ATRA Vesanoid 1995 $2,435 $3,777 bleomycin Blenoxane 1996 $421 $634 daunorubicin liposomal DanuoXome 1996 $847 $1,276 etoposide phosphate Etopophos 1996 $685 $1,032 gemcitabine Gemzar 1996 $2,129 $3,208 irinotecan Camptosar 1996 $5,326 $8,024 nilutamide Nilandron 1996 $320 $483 topotecan Hycamtin 1996 $2,344 $3,531 docetaxel Taxotere 1996 $2,610 $3,932 letrozole Femara 1997 $180 $265 rituximab Rituxan 1997 $3,475 $5,118 toremifene Fareston 1997 $93 $138 BCG Live TICE BCG 1998 $53 $77 capecitabine Xeloda 1998 $1,045 $1,515 leuprolide acetate Eligard, Lupron, Lupron Depot 1998 $206 $298 trastuzumab Herceptin 1998 $3,208 $4,652 valrubicin Valstar 1998 $3,209 $4,654 bexarotene Targretin 1999 $2,361 $3,351 busulfan Busulfex (Myleran) 1999 $1,427 $2,025 cytarabine liposomal DepoCyt, DepoFoam 1999 $3,351 $4,755 denileukin Ontak 1999 $14,291 $20,277 epirubicin Ellence 1999 $2,295 $3,256 exemestane Aromasin 1999 $205 $291 methoxsalen Uvadex 1999 $80 $113 temozolomide Temodar 1999 $1,574 $2,233 arsenic trioxide Trisenox 2000 $5,400 $7,413 gemtuzumab ozogamicin Mylotarg 2000 $4,262 $5,851 triptorelin pamoate Trelstar Depot 2000 $450 $617 alemtuzumab Campath 2001 $19,925 $26,595 imatinib mesylate Gleevec 2001 $3,401 $4,540 fulvestrant Faslodex 2002 $948 $1,246 ibritumomab tiuxetan Zevalin 2002 $1,000 $1,313 oxaliplatin Eloxatin 2002 $5,911 $7,767 zoledronic acid Zometa 2002 $881 $1,157 abarelix Plenaxis depot 2003 $2,607 $3,350 bortezomib Velcade 2003 $3,392 $4,358 gefitinib Iressa 2003 $1,608 $2,066 tositumomab Bexxar 2003 $1,449 $1,862 azacitidine Vidaza, Mylosar 2004 $3,909 $4,892 bevacizumab Avastin 2004 $4,429 $5,542 cetuximab Erbitux 2004 $9,465 $11,844 erlotinib Tarceva 2004 $4,174 $5,223 pemetrexed disodium Alimta 2004 $5,086 $6,364 lenalidomide Revlimid 2005 $7,989 $9,670 nelarabine Arranon 2005 $19,425 $23,511 paclitaxel albumin-stabilized Abraxane, Nanoparticle nanoparticle formulation Paclitaxel 2005 $5,640 $6,826 sorafenib Nexavar 2005 $5,097 $6,169 dasatinib Sprycel 2006 $4,529 $5,310 decitabine Dacogen 2006 $4,652 $5,455 panitumumab Vectibix 2006 $7,991 $9,370 sunitinib maleate Sutent 2006 $4,590 $5,382 thalidomide Thalomid, Synovir 2006 $5,613 $6,581 vorinostat Zolinza 2006 $8,134 $9,537 ixabepilone Ixempra 2007 $6,781 $7,731 lapatinib ditosylate Tykerb 2007 $3,124 $3,562 nilotinib Tasigna 2007 $6,140 $7,000 temsirolimus Torisel 2007 $5,497 $6,267 degarelix Firmagon 2008 $595 $653 bendamustine HCL Treanda 2008 $7,026 $7,714 everolimus Afinitor 2009 $7,885 $8,688 pralatrexate injection Folotyn 2009 $19,732 $21,741 pazopanib Votrient 2009 $6,013 $6,625 romidepsin Istodax 2009 $16,958 $18,685 ofatumumab Arzerra 2009 $18,315 $19,854 cabazitaxel Jevtana Injection 2010 $10,842 $11,754 sipuleucel-T Provenge 2010 $35,588 $38,580 eribulin mesylate Halaven 2010 $6,193 $6,714 ipilimumab Yervoy 2011 $37,956 $39,888 vandetanib Caprelsa 2011 $10,413 $10,943 abiraterone acetate Zytiga 2011 $5,259 $5,527 vemurafenib tablets Zelboraf 2011 $10,767 $11,315 brentuximab vedotin Adcetris 2011 $19,495 $20,487 crizotinib Xalkori 2011 $11,011 $11,571 asparaginase Erwinia chrysanthemi Erwinaze 2011 $24,622 $24,984 ruxolitinib phosphate Jakafi 2011 $8,865 $8,865 axitinib Inlyta 2012 $9,291 $9,566 vismodegib Erivedge 2012 $8,546 $8,799 ziv-aflibercept Zaltrap 2012 $11,063 $11,390 enzalutamide Xtandi 2012 $7,078 $7,287 bosutinib Bosulif 2012 $8,287 $8,532 regorafenib Stivarga 2012 $9,620 $9,905 omacetaxine mepesuccinate Synribo 2012 $6,357 $6,545 cabozantinib Cometriq 2012 $9,921 $10,214 ponatinib Iclusig 2012 $9,104 $9,373 carfilzomib Kyprolis 2012 $7,959 $8,077 pertuzumab Perjeta 2012 $7,758 $7,872 ado-trastuzumab emtansine Kadcyla 2013 $10,635 $10,791 pomalidomide Pomalyst 2013 $11,336 $11,502 trametinib Mekinist 2013 $8,812 $8,942 dabrafenib Tafinlar 2013 $9,411 $9,549 Ra 223 Xofigo 2013 $12,455 $12,638 ibrutinib Imbruvica 2013 $10,900 $11,060 obinutuzumab Gazyva 2013 $5,878 $5,964 afatanib Gilotrif 2013 $6,071 $6,071 ceritinib Zykadia 2014 $13,672 $13,672 ramucirumab Cyramza 2014 $13,256 $13,256 pembrolizumab Keytruda 2014 $8,725 $8,725 blinatumomab Blincyto 2014 $64,260 $64,260